These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 34251354)
1. The Management of Pulmonary Fibrosis in COVID-19. Rumende CM; Susanto EC; Sitorus TP Acta Med Indones; 2021 Apr; 53(2):233-241. PubMed ID: 34251354 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment. Rumende CM Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340 [TBL] [Abstract][Full Text] [Related]
3. Extension of Collagen Deposition in COVID-19 Post Mortem Lung Samples and Computed Tomography Analysis Findings. Ball L; Barisione E; Mastracci L; Campora M; Costa D; Robba C; Battaglini D; Micali M; Costantino F; Cittadini G; Patroniti N; Pelosi P; Fiocca R; Grillo F Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299124 [TBL] [Abstract][Full Text] [Related]
5. Post-ARDS pulmonary fibrosis in patients with H1N1 pneumonia: role of follow-up CT. Mineo G; Ciccarese F; Modolon C; Landini MP; Valentino M; Zompatori M Radiol Med; 2012 Mar; 117(2):185-200. PubMed ID: 22020433 [TBL] [Abstract][Full Text] [Related]
6. Post covid 19 pulmonary fibrosis. Is it real threat? Rai DK; Sharma P; Kumar R Indian J Tuberc; 2021 Jul; 68(3):330-333. PubMed ID: 34099197 [TBL] [Abstract][Full Text] [Related]
7. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia. Yu M; Liu Y; Xu D; Zhang R; Lan L; Xu H Korean J Radiol; 2020 Jun; 21(6):746-755. PubMed ID: 32410413 [TBL] [Abstract][Full Text] [Related]
8. [Update 2021: Pulmonary Sequelae of COVID-19 Pneumonia]. Leo F; Meybaum C; Wormanns D; Grohé C Dtsch Med Wochenschr; 2021 Jul; 146(13-14):927-932. PubMed ID: 34256411 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary fibrosis secondary to COVID-19: a call to arms? Spagnolo P; Balestro E; Aliberti S; Cocconcelli E; Biondini D; Casa GD; Sverzellati N; Maher TM Lancet Respir Med; 2020 Aug; 8(8):750-752. PubMed ID: 32422177 [No Abstract] [Full Text] [Related]
10. Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study. Li X; Shen C; Wang L; Majumder S; Zhang D; Deen MJ; Li Y; Qing L; Zhang Y; Chen C; Zou R; Lan J; Huang L; Peng C; Zeng L; Liang Y; Cao M; Yang Y; Yang M; Tan G; Tang S; Liu L; Yuan J; Liu Y Respir Res; 2021 Jul; 22(1):203. PubMed ID: 34243776 [TBL] [Abstract][Full Text] [Related]
11. Exercise-based pulmonary rehabilitation for a post-COVID-19 pulmonary fibrosis patient: A case report. Choi K; Kim M; Lee SM; Kim J Medicine (Baltimore); 2021 Nov; 100(47):e27980. PubMed ID: 34964792 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary Function and Chest Computed Tomography (CT) Scan Findings After Antifibrotic Treatment for COVID-19-Related Pulmonary Fibrosis. Lomanta JMJ; Quinto ML; Urquiza SC; Santiaguel JM Am J Case Rep; 2022 Feb; 23():e934830. PubMed ID: 35152259 [TBL] [Abstract][Full Text] [Related]
14. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge. Wei J; Yang H; Lei P; Fan B; Qiu Y; Zeng B; Yu P; Lv J; Jian Y; Wan C J Xray Sci Technol; 2020; 28(3):383-389. PubMed ID: 32474479 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial. Lu ZH; Yang CL; Yang GG; Pan WX; Tian LG; Zheng JX; Lv S; Zhang SY; Zheng PY; Zhang SX Infect Dis Poverty; 2021 Mar; 10(1):31. PubMed ID: 33731163 [TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes of post-COVID-19 pulmonary fibrosis: A case-control study. Farghaly S; Badedi M; Ibrahim R; Sadhan MH; Alamoudi A; Alnami A; Muhajir A Medicine (Baltimore); 2022 Jan; 101(3):e28639. PubMed ID: 35060549 [TBL] [Abstract][Full Text] [Related]
17. Post-COVID pulmonary fibrosis: therapeutic efficacy using with mesenchymal stem cells - How the lung heals. Vishnupriya M; Naveenkumar M; Manjima K; Sooryasree NV; Saranya T; Ramya S; Harysh Winster S; Paulpandi M; Balachandar V; Arul N Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2748-2751. PubMed ID: 33829461 [TBL] [Abstract][Full Text] [Related]
18. [COVID-19: A Pneumological Point of View - Long-Term Sequelae of COVID-19 - Implications For Follow-up In Respiratory Medicine]. Leo F; Wormanns D; Grohé C Dtsch Med Wochenschr; 2020 Jul; 145(15):1086-1092. PubMed ID: 32731284 [TBL] [Abstract][Full Text] [Related]
19. Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients. Hu ZJ; Xu J; Yin JM; Li L; Hou W; Zhang LL; Zhou Z; Yu YZ; Li HJ; Feng YM; Jin RH Front Immunol; 2020; 11():585647. PubMed ID: 33133104 [TBL] [Abstract][Full Text] [Related]
20. Association of Paraspinal Muscle Measurements on Chest Computed Tomography With Clinical Outcomes in Patients With Severe Coronavirus Disease 2019. Feng Z; Zhao H; Kang W; Liu Q; Wu J; Bragazzi NL; Ma X; Wang W; Rong P J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):e78-e84. PubMed ID: 33355656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]